BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7898368)

  • 1. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
    Vera DR; Stadalnik RC; Kudo M; Krohn KA
    Methods Enzymol; 1994; 247():402-9. PubMed ID: 7898368
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples.
    Vera DR; Topcu SJ; Stadalnik RC
    Methods Enzymol; 1994; 247():394-402. PubMed ID: 7898367
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo quantification of asialoglycoprotein receptor.
    Kudo M; Vera DR; Stadalnik RC
    Methods Enzymol; 1994; 247():373-82. PubMed ID: 7898365
    [No Abstract]   [Full Text] [Related]  

  • 4. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
    Vera DR; Stadalnik RC; Krohn KA
    J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
    Yang W; Mou T; Zhang X; Wang X
    Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].
    Pang Q; Yang L; Zhong Y; Guan C; Zhao Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):368-71. PubMed ID: 1814813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
    Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
    Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
    Vera DR; Woodle ES; Stadalnik RC
    J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
    Stadalnik RC; Kudo M; Eckelman WC; Vera DR
    Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.
    Vera DR; Krohn KA; Scheibe PO; Stadalnik RC
    IEEE Trans Biomed Eng; 1985 May; 32(5):312-22. PubMed ID: 3997184
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
    Pimstone NR; Stadalnik RC; Vera DR; Hutak DP; Trudeau WL
    Hepatology; 1994 Oct; 20(4 Pt 1):917-23. PubMed ID: 7927233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 labeled galactosyl-neoglycoalbumin for imaging the hepatic asialoglycoprotein receptor.
    Yang W; Mou T; Peng C; Wu Z; Zhang X; Li F; Ma Y
    Bioorg Med Chem; 2009 Nov; 17(21):7510-6. PubMed ID: 19796957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
    Lin J; Qiu L; Cheng W; Luo S; Ye W
    Nucl Med Biol; 2011 Jul; 38(5):619-29. PubMed ID: 21718936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
    Vera DR
    J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
    Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
    J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
    Kurtaran A; Li SR; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
    J Nucl Med; 1995 Oct; 36(10):1875-81. PubMed ID: 7562058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.